New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Blood sample of patient positive tested for sickle cell. Kitsawet Saethao | Istock | Getty Images The approval of two gene therapies to treat sickle cell disease has given hope to patients who suffer from the debilitating disease, which overwhelmingly affects Black people and people of … Read more

Novavax to settle dispute over canceled Covid vaccine purchase agreement

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images Novavax on Thursday said it will settle a bitter arbitration … Read more

Moderna posts surprise quarterly profit even as Covid vaccines sales plummet

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Nikos Pekiaridis | Nurphoto | Getty Images Moderna on Thursday posted a surprise quarterly profit, in part boosted by deferred revenue, even as the company saw slumping sales from its Covid vaccine, its only marketable product.  The results cap a rocky year for the biotech company and … Read more

Nearly all doctors feel burnout, but many are encouraged by potential of AI, survey says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Suriyapong Thongsawang | Moment | Getty Images Doctors in the U.S. are struggling to contend with burnout, staffing shortages and overwhelming administrative workloads, but many are optimistic that artificial intelligence could help to ease these problems, a new survey found.  More than 90% of physicians report … Read more

Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Good afternoon! The launch of the closely watched Alzheimer’s drug Leqembi is off to a slow start. Still, demand for the treatment from Biogen and its Japanese partner Eisai is rising. That’s the update the two drugmakers gave Wall Street during their latest quarterly earnings calls earlier … Read more

AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021. Dado Ruvic | Reuters AbbVie on Tuesday said longtime executive Robert Michael will become the company’s new CEO, replacing Richard Gonzalez.  Michael, who is AbbVie’s president and … Read more

What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Many U.S. companies are grappling with health insurance coverage issues for workers when it comes to GLP-1 drugs for weight loss. Despite the hefty price tag — typically between $1,000 to $1,500 a month — consumers are clamoring for drugs like Novo Nordisk‘s Wegovy and Eli … Read more

In this fast-paced bull market, we’re increasing our Club price targets on 4 stocks

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE It’s been hard to keep up. That’s the story of the big stock winners this year. They just keep winning and winning and winning. For analysts on Wall Street and here at the Club, it seems like some of these names are smashing through our six-to-nine-month … Read more

Biden administration examining role of supply chain middlemen in generic drug shortages

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A variety of generic pills and capsules.  Nenov | Moment | Getty Images The Federal Trade Commission on Wednesday said it is examining the role that drug wholesalers and companies that purchase medicines for U.S. health-care providers play in shortages of generic drugs, which account for … Read more

Healthy Returns: Higher medical costs are pinching insurers

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A UnitedHealth Group health insurance card is seen in a wallet, Oct.14, 2019. Lucy Nicholson | Reuters Good afternoon! Health insurers are feeling the squeeze as older patients head to the doctor more than expected. CVS, which owns health insurer Aetna, on Wednesday slashed its full-year profit outlook, … Read more

Here’s why we would be considering buying more Eli Lilly shares if they were down Tuesday

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. 1. U.S. stocks tumbled Tuesday on hotter-than-expected retail inflation data. The surprise uptick in the January consumer price index sent bond … Read more

Federal judge tosses lobbying group’s lawsuit challenging Medicare drug price negotiations

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna Moneymaker | Getty Images A federal judge on Monday tossed a lawsuit brought by a major pharmaceutical … Read more

Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen on Tuesday reported fourth-quarter revenue and profit that shrank from a year ago, as it recorded charges related to dropping its controversial Alzheimer’s drug Aduhelm and as sales slumped in its multiple sclerosis therapies, the company’s … Read more

Wall Street changes its tune on this healthcare stock. Why we were always bullish

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. U.S. stocks were modestly higher Monday as the market awaits key economic data. Traders will be mulling over the consumer … Read more

Defense Secretary Lloyd Austin re-hospitalized for bladder issue

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE US Defense Secretary Lloyd Austin takes questions during a press conference at the Pentagon in Washington, DC, on February 1, 2024.  Andrew Caballero-reynolds | Afp | Getty Images Defense Secretary Lloyd Austin was taken back to the hospital on Sunday afternoon for symptoms related to a … Read more

Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters The insatiable demand for weight loss drugs is trouncing supply, leaving many patients struggling to find the injectable treatments.  The dominant weight … Read more

Portfolio health care name turns its luck around thanks to management’s AI push

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. 1. U.S. stocks were mostly higher on Friday. The S & P 500 was on track for a fifth positive week … Read more

Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sen. Bernie Sanders, left, appears at a news conference with Sen. Ed Markey on issuing subpoenas for pharmaceutical company CEOs to testify regarding drug prices, in the Capitol, Jan. 25, 2024. Bill Clark | Cq-roll Call, Inc. | Getty Images Senators will question the CEOs of … Read more

Wall Street gives 2 of our healthcare stocks well-deserved price target bumps

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Wall Street liked what it saw from GE Healthcare and Eli Lilly in their earnings reports, leading to a round of well-deserved price target bumps for the Club stocks. Analysts at four equity research firms boosted their price targets for GE Healthcare since the maker of … Read more

CVS beats estimates, but cuts full-year profit outlook on higher medical costs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A CVS location in New York, US, on Thursday, Feb. 9, 2023. Stephanie Keith | Bloomberg | Getty Images CVS Health on Wednesday reported fourth-quarter revenue and adjusted earnings that topped expectations, but the company cut its full-year profit outlook, citing higher medical costs that are … Read more

GEHC stock finally gets some respect after earnings. Those betting against it got slammed

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Business at GE Healthcare Technologies capped off 2023 on a strong note despite ongoing concerns about China. That coupled with management’s upbeat view of this year propelled shares up more than 13% to over $83 each at session highs. That was their highest level since July … Read more

Healthy Returns: Novo Nordisk, Eli Lilly are tackling weight loss drug supply woes

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Good afternoon! All eyes are on Novo Nordisk and Eli Lilly again as Wall Street looks for signs that they can address one of the biggest hurdles they faced last year. Neither company has enough supply to meet the insatiable demand for their weight loss and diabetes drugs.  One month into 2024, the … Read more

Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023.  Brendan McDermid | Reuters Eli Lilly on Tuesday said its highly popular drug used for weight loss and diabetes showed promise as a treatment for fatty … Read more

Wall Street says Big Tech needs to take a breather after huge run. Here’s our take

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. 1. U.S. stocks were mixed Tuesday, on a muted performance from Big Tech. Citigroup strategists warned that tech stocks may stall … Read more

Eli Lilly results blow past estimates on strong Zepbound launch, higher Mounjaro prices

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly logo is shown on one of the company’s offices in San Diego, California, U.S., September 17, 2020.  Mike Blake | Reuters Eli Lilly on Tuesday reported fourth-quarter revenue and adjusted earnings that topped expectations on the strong launch of its new weight loss drug, Zepbound, … Read more

Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, November 21, 2023.  Victoria Klesty | Reuters Novo Nordisk‘s parent company on Monday said it will acquire drug manufacturer Catalent in a $16.5 billion deal that could help boost … Read more

Fourth-quarter earnings are shaping up to be the best of 2023, but there’s a catch

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., February 1, 2024.  Brendan McDermid | Reuters Here’s how big of a surprise corporate profits have been this earnings season: the fourth-quarter is now shaping up to be the … Read more

January was great for stocks — here are the top 5 performers in the portfolio

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Benchmark gauges notched all-time highs as stocks charged through a busy earnings season. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Bristol Myers Squibb results top estimates as new drugs post strong sales growth 

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Bristol Myers Squibb reported quarterly earnings and revenue that topped expectations on Friday as its portfolio of new drugs posted strong sales growth.  Here’s what the company reported for the fourth quarter compared with what Wall Street was expecting, based on a survey of analysts by … Read more

Ad giant Publicis paying $350 million to settle U.S. opioid crisis claims

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A sign for Publicis Groupe SA is seen at their headquarters in Paris, France, on Sunday, July 28, 2013.  Balint Porneczi | Bloomberg | Getty Images The healthcare division of French ad giant Publicis agreed to pay $350 million to settle claims that its past marketing … Read more

Neuralink competitor Synchron to ramp up brain implant production with equity stake in manufacturer

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Philip O’Keefe, one of Synchron’s patients in the SWITCH clinical trial, was the first person in the world to tweet using a BCI device. Source: Synchron Neurotech startup Synchron is ramping up production of its flagship brain-computer interface to prepare for commercial demand, as the company … Read more

Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The logo for Merck & Co. is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, New York, U.S., November 17, 2021.  Andrew Kelly | Reuters Merck on Thursday reported fourth-quarter revenue and adjusted earnings that topped estimates as it … Read more

We’re trimming a health-care stock ahead of earnings — hedging our bets on business in China

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We’re selling 95 shares of GE Healthcare at roughly $74. Following Wednesday’s trade, Jim Cramer’s Charitable Trust will own 1,150 shares of GEHC, reducing its weighting to 2.75% from 2.97%. The small trim we’re making in GE Healthcare with the stock up slightly in an otherwise … Read more

Biogen drops controversial Alzheimer’s drug Aduhelm to focus on Leqembi, experimental treatments

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The Biogen headquarters in Cambridge, Massachusetts, on Tuesday, Oct. 24, 2023. Vanessa Leroy | Bloomberg | Getty Images Biogen on Wednesday said it will discontinue the sale and development of its older and highly controversial Alzheimer’s drug Aduhelm to refocus the company’s efforts to treat the … Read more

GSK posts blowout RSV vaccine sales, raises outlook as shots give big pharma a boost

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020.  Dado Ruvic | Reuters GlaxoSmithKline on Wednesday lifted its long-term outlook following the smash-hit launch of its new RSV vaccine. The shot targeting the severe and in some cases life-threatening … Read more

Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Liselotte Sabroe | Afp | Getty Images Novo Nordisk, Europe’s largest company by market capitalization, on Wednesday reported better-than-expected 2023 earnings, as sales of its wildly popular anti-obesity and diabetes drugs continued to soar. The maker of weight loss drug Wegovy and diabetes drug Ozempic reported … Read more

Vertex non-opioid painkiller shows positive results in critical late-stage trial on acute pain

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston on Oct. 23, 2019. Brian Snyder | Reuters Vertex Pharmaceuticals on Tuesday said its experimental painkiller, which is being tested as an alternative to addictive opioids, significantly decreased post-surgery pain in late-stage … Read more

Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! This is Annika Kim Constantino, and I cover the biotech and pharmaceutical industry for CNBC.com.  Three names in the industry – Johnson & Johnson, Merck and … Read more

Symptoms from excessive screen time cost the U.S. $73 billion a year, study finds

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE American workers are spending too much time looking at screens. More than 104 million people in the U.S., including nearly 70% of people working office jobs, spend upwards of seven hours a day looking at screens, according to a Tuesday report from the Deloitte Economics Institute … Read more

Pfizer beats earnings estimates as declining Covid business performs better than expected

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pfizer CEO Albert Bourla talks during a press conference with European Commission President Ursula von der Leyen after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the factory of U.S. pharmaceutical company Pfizer in Puurs, Belgium April 23, 2021.  John Thys | … Read more

Elon Musk’s Neuralink implants brain tech in human patient for the first time

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jonathan Raa | Nurphoto | Getty Images Elon Musk‘s neurotech startup Neuralink implanted its device in a human for the first time on Sunday, and the patient is “recovering well,” the billionaire said in a post on X, formerly known as Twitter, on Monday. The company … Read more

Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium.  NYSE Big pharmaceutical companies such as Bristol Myers Squibb, Merck and Johnson & Johnson face a looming threat that will put tens of billions of dollars in sales at risk between now … Read more

Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE US Senator Bernie Sanders, Independent of Vermont, speaks during a rally by the People’s Action, protesting pharmaceutical companies’ lobbying against allowing Medicare to negotiate lower prescription drug prices, outside Pharmaceutical Research and Manufacturers of America (PhRMA) headquarters in Washington, DC, September 21, 2021. Saul Loeb | … Read more

Humana stock plunges on dismal 2024 forecast, as insurers face soaring medical costs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Signage is displayed on a Humana Inc. office building in Louisville, Kentucky, U.S., on Sunday, Feb. 3, 2019. Humana is scheduled to release earnings figures on February 6. Photographer: Luke Sharrett/Bloomberg via Getty Images Bloomberg | Bloomberg | Getty Images Shares of Humana plummeted on Thursday … Read more

Tyson Foods drops CVS for upstart pharmacy benefit manager, as industry upheaval over cost concerns spreads

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Tyson Foods Inc., sign at Tyson headquarters in Springdale, Ark. April L. Brown | AP Tyson Foods will become one of the first Fortune 100 companies to stop using the nation’s traditional large pharmacy benefits managers, as it looks to cut spending on high-cost drugs.    … Read more

Johnson & Johnson to settle talc baby powder investigation, will reportedly pay $700 million

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Containers of Johnson and Johnson baby powder are displayed on a Walgreens shelf on April 05, 2023 in San Anselmo, California. Justin Sullivan | Getty Images Johnson & Johnson has reached a tentative settlement to resolve an investigation by more than 40 states into whether the … Read more

Johnson & Johnson narrowly tops quarterly estimates as pharmaceutical, medtech sales jump

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The stock trading graph of Johnson & Johnson is seen on a smartphone screen. Rafael Henrique | SOPA Images | LightRocket | Getty Images Johnson & Johnson on Tuesday reported fourth-quarter earnings and revenue that narrowly edged out Wall Street’s expectations as sales in the company’s pharmaceutical … Read more

Gilead stock falls after disappointing lung cancer study results

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sopa Images | Lightrocket | Getty Images Shares of Gilead fell more than 9% on Monday after a key drug from the company did not significantly extend the lives of patients with a certain lung cancer in a late-stage trial. The results are a blow to … Read more

Why we like health-care stocks in 2024 despite their spotty record in presidential election years

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE As the old Wall Street adage goes, health care tends to underperform the stock market in presidential election years — and in recent cycles, that’s been true. But, there’s reason to believe this year that many health-related stocks, led by Eli Lilly , could defy historical … Read more

The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity.  Michael Siluk | UCG | Getty Images Drugmakers have been scrambling to join a two-horse race to lead … Read more

4 stock ideas I brought back from the JPMorgan Healthcare Conference and everything else I learned about the industry

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Health care may be a real challenger to tech this year, a business that can actually grow faster than most of tech and has the possibility of a comeback from the Covid straitjacket that so many of these companies got caught up in. The pandemic obscured … Read more

Defense Secretary Austin is ‘actively involved and engaged’ while hospitalized

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE US Secretary of Defense Lloyd J. Austin testifies before a House Armed Services Committee hearing on the conclusion of military operations in Afghanistan at the Rayburn House Office building on Capitol Hill on September 29, 2021 in Washington, DC.  Olivier Douliery | Afp | Getty Images … Read more

Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture Alliance | Getty Images SAN FRANCISCO — An established but promising group of cancer drugs was a red-hot market in 2023, and more companies could look to … Read more

Walgreens and 3 other health-care stocks are going into our Bullpen watch list

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We’re making our first Bullpen update of 2024. The Bullpen is a collection of stocks identified by the CNBC Investing Club team as having the potential to join Jim Cramer’s Charitable Trust. We’re highlighting the four most interesting investment opportunities we found out of the handful … Read more

CVS to close ‘select’ pharmacies in Target stores in the coming months

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A person walks by a CVS pharmacy store in Manhattan, New York, U.S., November 15, 2021. Andrew Kelly | Reuters CVS Health plans to close select pharmacies inside Target stores early this year, a company spokesperson said Thursday, as retail pharmacy chains in the U.S. struggle … Read more

YouTube taps hospitals to create videos to help people witnessing an overdose or heart attack

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE People walk past a billboard advertisement for YouTube in Berlin, Germany, on Sept. 27, 2019. Sean Gallup | Getty Images YouTube is taking steps to fight against medical misinformation, especially when it comes to finding immediate tips on how to handle an emergency. The company on … Read more

J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Monday said it will pay $2 billion in cash to acquire Ambrx Biopharma, a drugmaker specializing … Read more

Eli Lilly’s direct drug sales may not upend the industry alone – but others could follow suit

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sopa Images | Lightrocket | Getty Images Eli Lilly is shaking up the pharmaceutical industry with a new website offering telehealth prescriptions and direct home delivery of certain drugs, including its red-hot weight loss treatment Zepbound, to expand patient access.  The company’s direct-to-consumer push announced Thursday, … Read more

Florida wins first FDA approval to import cheaper drugs from Canada

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pharmacist Thomas Jensen, looks over a prescription drug at the Rock Canyon pharmacy in Provo, Utah, May 9, 2019. George Frey | Reuters The Food and Drug Administration on Friday approved Florida’s plan to import cheaper prescription drugs from Canada, a first-in-the-nation move that could reduce … Read more

Walgreens posts earnings beat but slashes quarterly dividend nearly in half

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A man walks near a Walgreens pharmacy on March 09, 2023 in New York City.  Leonardo Munoz | Corbis News | Getty Images Walgreens reported fiscal first-quarter adjusted earnings and revenue that topped expectations on Thursday, but cut its quarterly dividend nearly in half.  The retail … Read more

Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two years

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Artur Widak | Nurphoto | Getty Images Shares of Moderna jumped more than 15% on Tuesday after Oppenheimer upgraded the stock to “outperform,” saying the Covid vaccine maker could market five products by 2026. The upgrade follows a dismal 2023 for Moderna, whose only commercially available … Read more

Reckitt Benckiser unit recalls possibly contaminated baby formula powder, FDA says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Enfimil infant formula, made by Mead Johnson Nutrition Co., sits on display in a supermarket in New York, U.S. Daniel Acker | Bloomberg News | Getty Images Baby formula maker Reckitt Benckiser’s Mead Johnson Nutrition has voluntarily chosen to recall certain batches of baby formula powder … Read more

Biden administration’s Medicare drug price negotiations will face major tests in 2024

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna Moneymaker | Getty Images U.S. patients and drugmakers will get a first glimpse of how much Medicare … Read more

Obesity and Alzheimer’s drugs pack one-two punch to power Eli Lilly higher in 2024

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Investor optimism for Eli Lilly ‘s diabetes and obesity treatments in 2023 lifted the stock to its seventh annual gain in a row. In the new year, it should be the same old story. Shares of Eli Lilly have taken a breather over the past three … Read more

Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The New York Stock Exchange welcomes Bristol Myers Squibb on Nov. 20th, 2020. NYSE Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per share. Karuna’s stock popped more than 47% on the news … Read more

Here are the big health sector themes to watch next year

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. David W. Cerny | Reuters The health-care sector has wiped out much of its losses for the year during the December market rally. Beaten-down biotech and medical device … Read more

Asia’s year in review: Who had it good — and who had it bad — in 2023

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Curtis S. Chin, a former U.S. ambassador to the Asian Development Bank, is managing director of advisory firm RiverPeak Group. Jose B. Collazo is an analyst focusing on the Indo-Pacific region. Follow them on X at @CurtisSChin and @JoseBCollazo. As 2023 comes to a close, we … Read more

Singapore’s latest Covid spike may be peaking, but don’t stop vaccinating, health minister says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE SINGAPORE — Singapore’s latest spike in Covid cases may be starting to peak — but the public needs to stay up to date on vaccinations, Health Minister Ong Ye Kung told CNBC on Thursday. Singapore reported 56,043 Covid cases in the week of Dec. 3 to … Read more

Weight loss drugs, Alzheimer’s treatments and gene editing: Enormous firsts defined 2023 in pharma

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Soumyabrata Roy | Nurphoto | Getty Images Drugmakers are closing out a year when they achieved several historic firsts that will shape the pharmaceutical industry in 2024 and beyond.  The weight loss drug market transformed into the pharmaceutical industry’s newest gold rush this year, as demand … Read more

SEC charges ex-CEO of medical device company with fraud, says some devices were ‘just a piece of plastic’

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The headquarters of the U.S. Securities and Exchange Commission (SEC) is seen in Washington, D.C., May 12, 2021. Andrew Kelly | Reuters Laura Tyler Perryman, co-founder and former CEO of the medical device startup Stimwave Technologies, was charged with allegedly defrauding investors out of $41 million … Read more

Here’s a rapid-fire update on all 33 stocks in our portfolio, including those Cramer would buy on dips

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jim Cramer ran through all 33 stocks in his Charitable Trust portfolio during the December edition of the CNBC Investing Club’s Monthly Meeting. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

The weight loss drug boom isn’t over yet — here’s what to expect in the year ahead

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE George Frey | Bloomberg | Getty Images Weight loss drugs exploded into the public eye this year, and 2024 will bring more change to the evolving market.  The drugs skyrocketed in popularity in 2023 as they helped patients shed significant weight, despite hefty price tags, mixed … Read more

New data on Eli Lilly’s weight-loss drug confirms its outlook is still bright

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The launch of Eli Lilly ‘s weight-loss drug Zepbound — a key pillar of our investment thesis in the pharmaceuticals giant — is going swimmingly in the U.S., Jefferies said Friday. Weekly Zepbound prescriptions totaled 7,700 in the week ended Dec. 8, its fourth on the … Read more

Moderna, Merck vaccine with Keytruda delays return of deadly skin cancer after 3 years, data says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE An exterior view of Moderna’s clinical manufacturing facility.  David L. Ryan | Boston Globe | Getty Images Moderna and Merck‘s experimental cancer vaccine, when used in combination with Merck’s blockbuster therapy Keytruda, reduced the risk of death or relapse in patients with the most deadly form … Read more

Vertex shares pop after non-opioid painkiller posts positive mid-stage trial results

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston, Massachusetts, U.S., October 23, 2019.  Brian Snyder | Reuters Shares of Vertex jumped Wednesday after the company’s painkiller, which is being tested as an alternative to opioids, significantly decreased pain in a … Read more

Google is rolling out new AI models for health care. Here’s how doctors are using them

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sundar Pichai, CEO of Google and Alphabet, speaks on artificial intelligence during a Bruegel think tank conference in Brussels, Belgium, on Jan. 20, 2020. Yves Herman | Reuters Google on Wednesday announced MedLM, a suite of new health-care-specific artificial intelligence models designed to help clinicians and … Read more

Weight gain after stopping Eli Lilly’s new obesity treatment should help, not hurt the stock

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Some Eli Lilly investors appear concerned about clinical trial data that showed patients regained weight after they stopped taking the company’s obesity drug Zepbound. The situation seems rather clear-cut to us: It’s no reason to sell. Eli Lilly shares on Tuesday shook off afternoon losses to … Read more

Patients regain weight after stopping Eli Lilly’s Zepbound, study says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly’s drug tirzepatide was approved for weight loss by the FDA. Courtesy of Eli Lilly Patients who took Eli Lilly‘s weight loss drug Zepbound regained around half of the weight they shed after stopping the newly approved treatment for a year, according to data released … Read more

Flying solo without Cigna will keep Humana focused on 2 big priorities in the year ahead

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE It looks like Cigna has scrapped its takeover bid for Club holding Humana , removing a dark cloud over both stocks that’s lingered since the acquisition talks surfaced nearly two weeks ago. Cigna and Humana were unable to agree on an acquisition price and other financial … Read more

Cigna shares jump on reports of abandoned Humana buyout, plans for $10 billion stock buyback

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sopa Images | Lightrocket | Getty Images Shares of Cigna jumped Monday following reports that the health-care giant has scrapped its plans to buy rival Humana due to disagreements on price, putting an early end to what would have been one of the largest deals of … Read more

Fraud in a bottle: How Big Pharma takes on criminals who make millions off counterfeit drugs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE In Las Vegas, Lazaro Hernandez was a flamboyant, jet-setting poker player shown in televised tournaments with stacks of colorful chips. But the casually dressed gambler spotted on security cameras with wads of cash at the casino cage was hiding a secret life. And federal investigators say … Read more

U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Blood sample tube with blood for Sickle Cell Screen -Test. Sickle cell blood test, abnormal hemoglobin test. Md Babul Hosen | Istock | Getty Images The U.S. Food and Drug Administration has approved the country’s first gene-editing treatment, Casgevy, for use in patients with sickle cell … Read more

U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE At age 19, Joe Tsogbe underwent his first hip replacement. In his 20s, he averaged about nine hospitalizations a year. By his 30s, that rose to more than a dozen.  All the result of sickle cell disease, an inherited blood disorder where a genetic mutation causes … Read more

Biden administration asserts power to seize drug patents in move to slash high prices

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE President Joe Biden speaks about protecting Social Security, Medicare, and lowering prescription drug costs, during a visit to OB Johnson Park and Community Center, in Hallandale Beach, Florida, on Nov. 1, 2022. Kevin Lamarque | Reuters The Biden administration on Thursday asserted its authority to seize … Read more

AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A sign stands outside a Abbvie facility in Cambridge, Massachusetts, May 20, 2021. Brian Snyder | Reuters AbbVie on Wednesday said it will acquire neuroscience drugmaker Cerevel Therapeutics for roughly $8.7 billion.  Under the terms of the deal, AbbVie will pay $45 per share for Cerevel. … Read more

Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The FDA approves Eli Lilly’s Zepbound, a weight loss drug similar to Ozempic and Wegovy. Courtesy: Eli Lilly Eli Lilly on Tuesday said its recently approved weight loss treatment Zepbound is now available at pharmacies across the U.S., serving as an alternative to rival obesity drugs … Read more

CVS to change how it prices prescription drugs with new pharmacy reimbursement model

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A sign outside a CVS Health store in Miami, Aug. 1, 2023. Joe Raedle | Getty Images CVS Health on Tuesday said will revamp how it prices prescription drugs and scrap a complex model that typically sets how much pharmacies get reimbursed and what patients pay … Read more

Reproductive startup launches test to identify an embryo’s genetic defects before an IVF pregnancy begins

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Noor Siddiqui, founder and CEO of Orchid, during the web summit for careers during Day 2 of the 2014 Web Summit in Dublin, Ireland, Nov. 5, 2014. Stephen McCarthy | Getty Images Reproductive technology startup Orchid on Tuesday announced a comprehensive new genetic test that may … Read more

Free ChatGPT may incorrectly answer drug questions, study says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Harun Ozalp | Anadolu | Getty Images The free version of ChatGPT may provide inaccurate or incomplete responses — or no answer at all — to questions related to medications, which could potentially endanger patients who use OpenAI’s viral chatbot, a new study released Tuesday suggests. … Read more

Roche enters obesity market with Carmot takeover but drugs may not be available until 2030

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE BRAZIL – 2021/11/26: In this photo illustration a F. HoffmannLa Roche AG logo is seen on a screen and a hand holding a pill. (Photo Illustration by Rafael Henrique/SOPA Images/LightRocket via Getty Images) Sopa Images | Lightrocket | Getty Images Swiss pharmaceuticals giant Roche is set … Read more

Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sopa Images | Lightrocket | Getty Images Pfizer’s twice-daily version of its experimental weight loss pill has now joined a long list of other scrapped drugs that aimed to treat obesity but came with unintended consequences.  The drugmaker on Friday said it will stop developing the … Read more

Why Pfizer’s latest stumble in the obesity market is a boon for Eli Lilly

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that’s good news for Club holding Eli Lilly (LLY) as it looks to maintain an edge in the fast-growing obesity-treatment market. Pfizer said Friday it will discontinue its twice-daily weight-loss … Read more

Why Pfizer’s latest stumble in the obesity market is a boon for Eli Lilly

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that’s good news for Club holding Eli Lilly (LLY) as it looks to maintain an edge in the fast-growing obesity-treatment market. Pfizer said Friday it will discontinue its twice-daily weight-loss … Read more

Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss pill after obese patients taking the drug lost weight but had trouble tolerating the drug in a mid-stage clinical study.  The drugmaker observed high rates of adverse side effects, which … Read more

Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A 0.25 mg injection pen of Novo Nordisk’s weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, August 31, 2023. Victoria Klesty | Reuters Novo Nordisk on Thursday said it sued two compounding pharmacies in Florida for allegedly selling impure and “potentially unsafe” … Read more

Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Test tubes are seen in front of a displayed Abbvie logo in this illustration taken, May 21, 2021. Dado Ruvic | Reuters Biotech stocks rose Thursday as AbbVie announced plans to buy cancer drug developer ImmunoGen for $10.1 billion.  Shares of ImmunoGen jumped more than 80% … Read more

Jim Cramer blasts the prospect of a Humana-Cigna deal — it could never be approved by regulators

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jim Cramer urged Humana (HUM) not to pursue a merger with rival health insurer Cigna (CI), questioning the merits of a potential business combination and the likelihood of it passing U.S. antitrust review. Cigna and Humana could reach an agreement on a stock-and-cash transaction by the … Read more

Nashville’s startup scene is booming. Here’s why investors and founders are moving to ‘Music City’

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE NASHVILLE, TENNESSEE – SEPTEMBER 1, 2019: Tourists visit the bars and country music venues in the Lower Broadway entertainment district in Nashville, Tennessee. (Photo by Robert Alexander/Getty Images) Robert Alexander | Archive Photos | Getty Images On a flight from Fort Lauderdale, Florida, to Nashville, Tennessee, … Read more

Covid vaccine rates in the U.S. are slumping — and it will be a challenge to boost them

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The new vaccine COMIRNATY® (Covid-19 vaccine, mRNA) by Pfizer, available at CVS Pharmacy in Eagle Rock, California. Irfan Khan | Los Angeles Times | Getty Images Three years into the Covid-19 pandemic, few Americans are rolling up their sleeves to get a Covid vaccine.  Only 15.7% … Read more

Cigna shares slide after report it could merge with Humana

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The Cigna Group headquarters in Bloomfield, Connecticut, US, on Friday, Oct. 27, 2023.  BlooJoe Buglewicz | Bloomberg | Getty Images Shares of Cigna slid on Wednesday after a report that the company is in talks with Humana about a merger between the two health care giants. … Read more

Jim Cramer knocks down a new analyst sell rating on a medtech stock as shortsighted

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. Wall Street was mixed Monday after the Dow , the S & P 500 and the Nasdaq finished higher for … Read more

Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A pharmacist displays a box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and made by Lilly at Rock Canyon Pharmacy in Provo, Utah, May 29, 2023. George Frey | Reuters The blockbuster diabetes drug Mounjaro is more effective for weight loss … Read more

Here’s how the American Red Cross makes money from donated blood

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The American Red Cross has long been recognized as the universal symbol of humanitarian services —and it’s an expensive operation. In 2022, the American Red Cross generated more than $3.2 billion in operating revenue and spent just over $3 billion in expenses the same year, according … Read more

China reports no ‘unusual or novel pathogens’ after WHO seeks data on respiratory illness outbreak

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Crowd gathers during China’s Lunar New Year celebrations. Nurphoto | Getty Images Chinese authorities reportedly called for vigilance Friday as a spike in respiratory illness continues to pile pressure on health care facilities in the north of the country, despite assurances that no “unusual or novel … Read more

U.S. to offer another round of free at-home Covid tests starting Monday

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE COVID-19 home test kits are pictured in a store window during the coronavirus disease (COVID-19) pandemic in the Manhattan borough of New York City, New York, U.S., January 19, 2022. Carlo Allegri | Reuters The Biden administration on Monday said it is offering another round of … Read more

‘The silent pandemic’: A hotter world makes it harder to stop the spread of deadly superbugs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A microbiologist at the Max-Planck-Institute for Infection Biology prepares a bacterial colony of the strain Streptococcus pyogenes on a blood agar plate. Picture Alliance | Picture Alliance | Getty Images Already recognized as one of the leading public health threats facing humanity today, it is feared that … Read more

CDC expedites release of more doses of infant RSV drug from Sanofi, AstraZeneca amid shortage

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A RSV-infected child receives treatment, as RS-Virus infections spread among children at Missio children’s clinic Moenchberg, in Wuerzburg, Germany, December 2, 2022.  Heiko Becker | Reuters The Centers for Disease Control and Prevention expedited the release of more than 77,000 additional doses of a new drug … Read more

Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE CFOTO | Future Publishing | Getty Images As its Covid gains evaporate, Pfizer wants a chunk of the budding weight loss drug market.  Analysts say upcoming data on Pfizer’s experimental obesity pill, danuglipron, will be crucial in determining how competitive the company can be against the … Read more

Amputees say this bionic hand startup gives them both strength and grace — they can even pick up raw eggs without crushing them

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Andrew Hitz with the Zeus hand. Courtesy of Aether Biomedical In 2011, Jeremy Schroeder was driving a four-wheeler near Sherwood, Ohio, when he crashed into a stop sign he hadn’t seen as the stone path suddenly turned to asphalt. The sign left a deep gash in … Read more

Novo Nordisk’s weight loss drug Wegovy slashes risk of serious heart events

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity.  Michael Siluk | UCG | Getty Images Novo Nordisk’s Wegovy cut the risk of serious cardiovascular complications in … Read more

Patients are lining up for $2,500 full-body MRI scans that can detect cancer early

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Prenuvo MRI machine Courtesy of Prenuvo While celebrating the July Fourth holiday last year on a boat in Tyler, Texas, Dr. Julianne Santarosa received the results from her full-body MRI scan. What she saw put a damper on the festivities. Radiologists at Prenuvo, which performed the … Read more

Amazon adds a new reason to get and keep Prime: member discounts on health-care services

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Amazon (AMZN) said on Wednesday that it’s offering Prime members a discount on its new health-care service — another perk that should help bring more people into the online retailer’s ecosystem. The One Medical service, which typically costs $199 annually, will be available to Prime subscribers … Read more

FDA approves Eli Lilly’s tirzepatide for weight loss, paving way for wider use of blockbuster drug

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, on March 29, 2023. George Frey | Reuters The Food and Drug Administration on Wednesday approved Eli Lilly‘s blockbuster … Read more

Pharmacy walkout organizers help launch national push to unionize pharmacists, technicians

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A small number of employees and supporters picket outside the headquarters of drugstore chain Walgreens during a three-day walkout by pharmacists in Deerfield, Illinois, November 1, 2023. Vincent Alban | Reuters The organizers of a recent retail pharmacy staff walkout are helping to launch a national … Read more

Health AI startup Cercle debuts with backing from Sheryl Sandberg

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sheryl Sandberg, former COO of Facebook, at Vanity Fair’s 6th Annual New Establishment Summit. Matt Winkelmeyer | Getty Images A new health tech startup called Cercle launched Wednesday and announced major global partners and investors, including Meta‘s former COO Sheryl Sandberg. Cercle uses artificial intelligence to … Read more

Planet Fitness shares surge as company raises revenue outlook

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A person works out at Planet Fitness as they re-open at 25 percent capacity in Boston’s Dorchester on Feb. 1, 2021. Jessica Rinaldi | Boston Globe | Getty Images Planet Fitness shares surged double-digits after beating expectations on both lines for the third quarter and raising … Read more

Wall Street is asking how weight-loss drugs will affect consumer giants — but it may be too early to tell

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A worker organizes cans of PepsiCo Inc. soda on a shelf inside a grocery store in Phoenix, Arizona, U.S., on Thursday, July 6, 2017. PepsiCo Inc. is scheduled to release earnings figures on July 11. Photographer: Caitlin O’Hara/Bloomberg via Getty Images Bloomberg | Bloomberg | Getty … Read more

E-cigarette use declines among high school students, FDA and CDC say

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Elf Bar disposable vape flavored vaping e-cigarette products are displayed in a convenience store on June 23, 2022 in El Segundo, California. – Vaping company Juul Labs said Thursday it would appeal a decision by the US Food and Drug Administration ordering all its products off … Read more

Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity.  Michael Siluk | UCG | Getty Images Novo Nordisk on Thursday said 80% of U.S. patients with insurance … Read more

Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, March 29, 2023. George Frey | Reuters Eli Lilly on Thursday said supply of its blockbuster diabetes drug Mounjaro … Read more

Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli Lilly on Thursday reported third-quarter revenue and adjusted earnings that topped estimates on strong demand for its diabetes drug Mounjaro, but slashed its full-year profit guidance due … Read more

Moderna posts quarterly loss as company takes $1.3 billion write-down on unused Covid shots

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Thursday posted a steep loss for the third quarter as the drugmaker recorded a large write-down due to unused Covid vaccines, its only marketable products.  Moderna’s total revenue for the period topped Wall Street’s expectations, even amid … Read more

The sell-off in Humana is overdone after strong earnings. Jim Cramer says buy the stock

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The post-earnings decline in Humana (HUM) shares Wednesday was overdone, providing investors an opportunity to add to their positions in the Medicare Advantage-focused health insurer. The Club holding remains on solid ground after delivering a top- and bottom-line beat in the third quarter. Revenue for the … Read more

Doctors have a new way to scrub personal information from internet after spike in harassment

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Doximity at the New York Stock Exchange for their IPO, June 24, 2021. Source: NYSE Doximity, the medical website that’s used by more than 80% of U.S. doctors, is now trying to protect its millions of members after a spike in harassment that started during the … Read more

CVS results top expectations, lifted by strong health services revenue

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A woman walks past a CVS Pharmacy in Washington, D.C., on Nov. 2, 2022. Brendan Smialowski | AFP | Getty Images CVS on Wednesday reported third-quarter adjusted earnings and revenue that topped Wall Street’s expectations, lifted in part by strong revenue from the company’s health services … Read more

Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE CFOTO | Future Publishing | Getty Images Pfizer on Tuesday reported a narrower than expected loss for the third quarter as the drugmaker recorded charges largely related to struggles for its Covid antiviral treatment Paxlovid and Covid vaccine. Pfizer said that it recorded a $5.6 billion … Read more

Some pharmacy staff from Walgreens, other chains are walking out again — here’s what you need to know

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A sign advertises COVID-19 (coronavirus) vaccine shots at a Walgreens Pharmacy in Somerville, Massachusetts, August 14, 2023. Brian Snyder | Reuters Some pharmacy staff from Walgreens and other drugstore chains are planning to walk out next week in the latest pushback against what they call unsafe … Read more

We had a busy week of trades in an oversold market. Here’s the day-by-day breakdown

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Elevated bond yields and geopolitical uncertainty continued to be negative for stocks this week as the overall market moved into oversold territory. However, that set us up to put cash to work and make four small buys as our discipline mandates. We also upgraded one of … Read more

Pharmacy staff from Walgreens, CVS say they’re at a breaking point — here’s what their days look like

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Signs offering COVID-19 vaccinations are seen outside of a CVS pharmacy in Washington, DC. Mandel Ngan | AFP | Getty Images Many pharmacy employees at some of the largest U.S. drugstore chains say they’re reaching a breaking point.  On top of verifying, filling and dispensing prescriptions, … Read more

Pfizer’s combination Covid, flu vaccine will move to final-stage trial after positive data

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE CFOTO | Future Publishing | Getty Images Pfizer on Thursday said its combination vaccine candidates targeting Covid and the flu will move to a final-stage trial in the coming months after showing positive initial results in an early to mid-stage study. That moves the pharmaceutical giant … Read more

Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Bristol Myers Squibb on Thursday reported quarterly adjusted earnings that topped expectations and posted revenue in line with estimates, even as sales of the company’s popular blood cancer drug Revlimid plummeted due to generic competition.  Bristol Myers, one of the world’s largest pharmaceutical companies, raked in … Read more

Merck results beat expectations on strong Keytruda, Gardasil and Covid drug growth

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Merck headquarters in Rahway, New Jersey, on Tuesday, April 18, 2023. Christopher Occhicone | Bloomberg | Getty Images Merck on Thursday reported third-quarter revenue and adjusted earnings that topped expectations on strong sales of its blockbuster cancer drug Keytruda, HPV vaccine Gardasil and surprisingly, its Covid … Read more

More convenient form of breakthrough Alzheimer’s drug Leqembi shows promising results in study

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eisai on Wednesday said an injectable version of the Alzheimer’s drug Leqembi showed promising initial results in a clinical trial, potentially paving the way for a new and more convenient option for administering the antibody treatment.  However, the injection did not cause lower rates of brain … Read more

RSV vaccine from GSK shows potential to protect adults 50 to 59

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A vaccine from GlaxoSmithKline showed the potential to protect adults ages 50 to 59 from respiratory syncytial virus in a late-stage clinical trial, the company said Wednesday. The initial trial results suggest that GSK’s shot, known as Arexvy, could help protect a wider population from RSV, … Read more

Picking health insurance can be tricky: 6 key terms to know as open enrollment starts

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sdi Productions | E+ | Getty Images Many people will soon be picking their health insurance plans for 2024: November is a common month for workplace open enrollment, and the public marketplace opens Nov. 1. But choosing a health plan can be tricky. In fact, a … Read more

We’re buying more of this life sciences stock after an earnings-driven decline

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The stock is under pressure in early trading due to uncertainty around the recovery in a key business. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Amazon considers offering veterinary telehealth as it looks to compete with Walmart

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Amazon is considering an expansion into veterinary telehealth in its latest bid to compete with Walmart, which began offering the service to Walmart+ subscribers earlier this year, people familiar with the matter told CNBC.  The e-commerce giant, which has already expanded into human health with its … Read more

As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Weight loss has always been big business, but it’s exploded of late due to surging demand for Ozempic, Wegovy and other new diabetes and obesity drugs. In the first half of 2023, sales of Ozempic and Wegovy rose by 58% and 363%, respectively. That’s after quarterly … Read more

Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Most analysts predict the market for new weight loss drugs like Wegovy and Mounjaro will be enormous, but estimates vary for its exact size depending on who you ask. On Monday, Citi raised its estimate for incretin drug sales to $71 billion by 2035, up from … Read more

CVS to pull certain cold medicines containing decongestant phenylephrine from store shelves

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Cold and flu medicine including NyQuil sit on a store shelf in Miami on Sept. 12, 2023. Joe Raedle | Getty Images CVS is removing some of the most common cough and cold medicines from its store shelves and will no longer sell them, a company … Read more

Sanofi to offer insulin product for $35 to all Americans through GoodRx

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sanofi Lantus brand insulin pens are arranged for a photograph in the Brooklyn borough of New York, U.S., on Friday, April 5, 2019. Alex Flynn | Bloomberg | Getty Images Americans, regardless of their insurance status, can now access Sanofi‘s most widely prescribed insulin for $35 … Read more

Pfizer to price Covid drug Paxlovid at $1,390 per course

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Paxlovid, Pfizer’s anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture illustration taken October 7, 2022. Wolfgang Rattay | Reuters Pfizer will price a five-day course of its Covid antiviral drug Paxlovid at $1,390 when the company starts to transition it to … Read more

Amazon begins delivering medications by drone in Texas

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Amazon announced Friday it will soon begin making drone deliveries in College Station, Texas. Amazon Amazon Pharmacy customers located in College Station, Texas can now have their prescription medications delivered by drone, the company announced in a blog post Wednesday. Eligible customers can access more than … Read more

Johnson & Johnson beats on earnings and hikes outlook as medtech, pharmaceutical sales surge

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Tuesday reported adjusted earnings and revenue that topped Wall Street’s expectations, driven by a surge in sales … Read more

Rite Aid files for bankruptcy amid slowing sales, opioid litigation

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A Rite Aid store stands in Brooklyn on August 28, 2023 in New York City. Spencer Platt | Getty Images Rite Aid has filed for bankruptcy.  The beleaguered drugstore chain has been grappling with slowing sales, mounting debt and a slew of lawsuits that allege the … Read more

When is it OK to violate your cost basis to buy more shares of a company?

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Here’s our Club Mailbag email investingclubmailbag@cnbc.com — so you send your questions directly to Jim Cramer and his team of analysts. We can’t offer personal investing advice. We will only consider more general questions about the investment process or stocks in the portfolio or related industries. … Read more

Pfizer slashes full-year earnings and revenue guidance as Covid treatment, vaccine sales slump

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pfizer CEO Albert Bourla talks during a press conference with the president of the European Commission after a visit to oversee the production of the Pfizer-BioNTech Covid-19 vaccine at the factory of U.S. pharmaceutical company Pfizer, in Puurs, Belgium, April 23, 2021. John Thys | AFP … Read more

Pharmacy staff from Walgreens, other chains could stage nationwide walkout and rallies in coming weeks

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A woman walks near a Walgreens pharmacy on March 09, 2023 in New York City.  Leonardo Munoz | Corbis News | Getty Images Pharmacy staff from Walgreens are laying the groundwork for a nationwide walkout and multiple rallies at the end of October to protest unsatisfactory … Read more

Biden praises Kaiser Permanente labor agreement after worker strike: ‘Collective bargaining works’

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Healthcare workers strike in front of Kaiser Permanente Los Angeles Medical Center, as more than 75,000 Kaiser Permanente healthcare workers go on strike from October 4 to 7 across the United States, in Los Angeles, California, October 4, 2023. Aude Guerrucci | Reuters More than 85,000 … Read more

The U.S. has high maternal mortality rates — and it has gotten worse for Latinas

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Zaza Cristina Robles worked as a pregnancy coach in her native Peru, so when she arrived in the U.S. at 16 weeks pregnant, the first thing she did after settling in with her in-laws was to seek medical care. “When they showed us the bill, it … Read more

New RSV protections for infants hit cost, insurance hurdles in U.S. rollout

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A doctor vaccinates an infant against respiratory syncytial virus (RSV) in a treatment room of her paediatric practice. Swen Pförtner | Picture Alliance | Getty Images Two new immunizations promise to protect babies from respiratory syncytial virus – if people can find them. Providers are scrambling … Read more

Novo Nordisk hikes outlook on soaring demand for Wegovy, Ozempic

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE An Ozempic injection pen is seen on a kitchen table in Riga, Latvia, on Aug. 6, 2023. Jaap Arriens | Nurphoto | Getty Images Novo Nordisk on Friday raised its outlook for its full-year sales and operating profit due to soaring demand for its blockbuster weight … Read more

UnitedHealth is back and lifting other health-care stocks with it, Jim Cramer says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Traders work at the post where UnitedHealth Group is traded on the floor of the New York Stock Exchange. Brendan McDermid | Reuters UnitedHealth Group‘s (UNH) quality quarterly results Friday are a good sign for the broader health-care landscape, CNBC’s Jim Cramer said. The managed-care giant … Read more

Here are 3 stocks in our portfolio that Goldman Sachs think will rally on earnings

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE It’s encouraging to see three Club stocks on the bullish side of Goldman Sachs’ new list of 25 tactical trades for earnings season. Asset allocation can be strategic or tactical. Strategic asset allocation generally refers to longer-term investing — think of this as your buy-and-hold approach. … Read more

Incoming Walgreens CEO doesn’t mention walkouts as he praises pharmacy staff

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Tim Wentworth, CEO of Express Scripts.  David A. Grogan | CNBC Incoming Walgreens CEO Tim Wentworth on Thursday briefly praised the company’s pharmacy staff, but made no mention of the three-day protest walkouts they held this week over poor working conditions. The walkouts reflect rising dissatisfaction … Read more

Walgreens profit outlook comes up short as demand declines for Covid vaccines and tests

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A man walks near a Walgreens pharmacy on March 09, 2023 in New York City.  Leonardo Munoz | Corbis News | Getty Images Walgreens on Thursday offered soft profit guidance and reported fiscal fourth-quarter earnings that fell short of expectations, as demand for Covid vaccines and … Read more

Monthly Meeting Q&A with Jim Cramer on everything from tech to health care to industrials

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE During the October Monthly Meeting , we took questions directly from Investing Club members. Here are Jim Cramer’s and portfolio director Jeff Marks’ responses. Their answers have been edited for clarity. 1. Why do rising interest rates have such a negative effect on technology stocks? (Rod) … Read more

Here’s a rapid-fire update on all 36 stocks in our portfolio, including our latest addition

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jim Cramer ran through the names during the Club’s October Monthly Meeting on Wednesday. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Jim Cramer praises Walgreens new CEO pick, says buy the stock ‘perhaps aggressively’

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE CNBC’s Jim Cramer on Wednesday praised the incoming CEO of Walgreens Boots Alliance, saying industry veteran Tim Wentworth is the right choice to lead the struggling pharmacy chain in its transition to offering more health-care services. “This guy is the real deal. I just salute him … Read more

Period care brands August, Rael and others form coalition to fight the ‘tampon tax,’ reimburse consumers

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Starting Wednesday, consumers paying state sales tax on menstrual products will be able to get those costs on some period care purchases reimbursed. The Tampon Tax Back Coalition — an initiative of period care brands August, Cora, LOLA, The Honey Pot, Rael, Here We Flo, Saalt … Read more

Walgreens names veteran health-care executive Tim Wentworth as next CEO

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A Walgreens sign is displayed on the window of one of its stores in Hollywood, California, on March 9, 2023. Stefani Reynolds | AFP | Getty Images Walgreens Boots Alliance has chosen veteran health care executive Tim Wentworth as the company’s new chief executive. Wentworth is … Read more

15 stocks with a history of dividend growth are expected to deliver once again this year

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Broadcom (AVGO), Caterpillar (CAT) and Eli Lilly (LLY) are among the 15 Club stocks with a streak of annual dividend growth that Wall Street expects to continue in their current fiscal years. Long-term investors should look to own companies with a history of dividend growth instead … Read more

As Covid testing business drops, Abbott searches for new line of business with consumer wearables

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Abbott Chairman of the Board and CEO Robert B. Ford delivers a keynote address at CES 2022 at The Venetian Las Vegas on January 6, 2022 in Las Vegas, Nevada. Ethan Miller | Getty Images Abbott Laboratories CEO Robert Ford took the stage at the HLTH … Read more

Microsoft announces new AI tools to help doctors deliver better care

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Microsoft CEO Satya Nadella listens to an audience member’s question during the company’s annual shareholder meeting in Bellevue, Washington, Nov. 30, 2016. Stephen Brashear | Getty Images News | Getty Images Microsoft on Tuesday announced new data and artificial intelligence products that aim to help health-care … Read more